Arcturus Therapeutics Holdings ARCT Cash Flow Statement (2018-2026)

NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Arcturus Therapeutics Holdings Quarterly Cash Flow Statement

Periods 33 quarters
Latest Jun 2026

Arcturus Therapeutics Holdings reported cash from operations of -$19.91M and free cash flow of -$19.91M for the quarter ended Jun 2026, down 246.0% year over year. This cash flow statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-53.82M-37.65M-51.27M-21.56M-35.27M118.64M50.75M-52.57M-16.23M-11.68M-26.85M-17.17M-6.90M-30.00M-14.08M-9.18M-13.45M-29.07M-28.93M-23.79M
Share-based CompensationStock Comp.
6.87M7.52M7.37M8.75M9.44M0.42M8.18M8.38M9.27M8.81M10.09M10.75M10.75M8.98M10.75M10.75M10.75M6.82M10.75M10.75M
Asset Writedowns and ImpairmentWritedown
1.30M1.90M
Cash from OperationsCash from Ops.
-16.65M-42.50M-49.04M-36.82M-42.41M160.26M-35.87M50.81M-32.41M-0.63M-5.56M-30.14M-23.76M-0.28M-35.14M-5.75M-17.15M-16.23M-19.44M-19.91M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.30M0.30M0.22M0.40M0.40M0.53M0.60M0.70M0.80M0.86M0.90M0.90M0.90M0.82M0.80M0.80M0.80M0.68M0.70M0.60M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.15M1.35M0.32M-1.44M-0.20M0.72M89.72M-89.68M35.42M-6.16M-5.01M-2.97M6.11M-26.23M10.60M2.63M-9.25M-2.39M-4.22M0.47M
Change in Account PayablesChange Payables
-1.78M1.80M-0.04M-4.38M9.76M-8.45M11.79M-6.20M4.90M-12.73M3.87M4.76M-3.77M-2.94M-1.01M4.44M-5.04M-1.34M-0.14M0.32M
Change in Accured ExpensesChange Accured Exp.
-4.16M-9.44M-3.55M9.41M-3.85M7.43M0.99M-3.97M-0.45M2.85M2.34M0.29M-3.26M6.56M-8.24M-6.06M-5.42M4.45M-1.23M0.17M
Other Working Capital ChangesOther WC Changes
38.19M-2.70M-3.71M-27.76M-22.10M38.88M10.34M14.63M8.99M4.65M-4.01M-29.61M-13.43M-8.16M-9.82M-2.27M-8.99M-2.80M-0.64M-1.33M
Investing Activities
Capital ExpendituresCapex
1.77M1.12M2.11M0.02M1.78M3.81M0.69M0.35M0.98M0.88M0.24M0.33M0.08M0.14M0.18M-0.09M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.03M0.02M
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
-1.77M-1.12M-2.11M0.38M-2.19M-3.81M-0.69M-0.35M-0.98M-0.88M-0.24M-0.33M-0.08M-0.14M-0.18M0.09M0.03M0.02M
Financing Activities
Other financing activitiesOther financing
0.18M0.23M0.34M0.26M0.37M0.77M1.23M1.34M2.19M2.40M0.01M0.13M0.20M0.27M0.64M0.02M
Cash from Financing ActivitiesCash from Financing
0.69M0.23M0.34M0.26M-1.22M-2.23M-27.36M0.09M21.84M-18.66M2.19M2.40M0.69M0.13M15.20M-14.73M1.23M11.69M0.02M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.70M2.98M2.14M0.74M2.03M
Net Equity Issued and RepurchasedNet Equity Issued
11.70M
Additional items
Change in Cash
-17.73M-43.38M-50.81M-36.19M-45.81M154.22M-63.93M50.55M-11.55M-20.16M-3.61M-28.07M-23.15M-0.15M-20.08M-20.48M-16.11M-4.45M-19.39M-19.89M
Free Cash FlowFCF
-18.42M-43.62M-51.15M-36.84M-44.19M156.45M-36.56M50.45M-33.39M-1.50M-5.80M-30.47M-23.84M-0.28M-35.27M-5.75M-17.33M-16.14M-19.44M-19.91M
Net Cash FlowNCF
-17.73M-43.38M-50.81M-36.19M-45.81M154.22M-63.93M50.55M-11.55M-20.16M-3.61M-28.07M-23.15M-0.15M-20.08M-20.48M-16.11M-4.45M-19.39M-19.89M